- Home
- PASG vs HBIO Comparison
PASG vs HBIO Comparison
Compare PASG & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PASG | HBIO |
|---|---|---|
| Founded | 2017 | 1901 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.3M | 33.8M |
| IPO Year | 2020 | 2000 |
Fundamental Metrics
Financial Performance| Metric | PASG | HBIO |
|---|---|---|
| Price | $9.95 | $0.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $34.50 | $2.50 |
| AVG Volume (30 Days) | 46.5K | ★ 1.0M |
| Earning Date | 11-10-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $87,371,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.22 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.12 | $0.28 |
| 52 Week High | $20.20 | $2.36 |
Technical Indicators
Market Signals| Indicator | PASG | HBIO |
|---|---|---|
| Relative Strength Index (RSI) | 58.94 | 55.75 |
| Support Level | $9.72 | $0.71 |
| Resistance Level | $10.71 | $0.78 |
| Average True Range (ATR) | 0.84 | 0.07 |
| MACD | 0.11 | -0.01 |
| Stochastic Oscillator | 73.25 | 43.26 |
Price Performance
Historical ComparisonAbout PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.